Document is current
Any future updates will be listed below
-
Authors
Garnier-Crussard, Antoine
Bougacha, Salma
Wirth, Miranka
André, Claire
Delarue, Marion
Landeau, Brigitte
Mézenge, Florence
Kuhn, Elizabeth
Gonneaud, Julie
Chocat, Anne
Quillard, Anne
Ferrand-Devouge, Eglantine
de La Sayette, Vincent
Vivien, Denis
Krolak-Salmon, Pierre
Chételat, Gaël http://orcid.org/0000-0002-4889-7932
-
Funding
Funding for this research was provided by:
Institut National de la Santé et de la Recherche Medicale
Programme Hospitalier de Recherche Clinique (PHRCN 2011-A01493-38)
Programme Hospitalier de Recherche Clinique (2012 12-006-0347)
Agence Nationale de la Recherche
Fondation Plan Alzheimer
Fondation LECMA-Vaincre Alzheimer (13732)
Association France Alzheimer et maladies apparentées, the Région Basse-Normandie
Agence régionale de santé Auvergne-Rhône-Alpes
Horizon 2020 (667696)
- License Information
-
More Information
Article History
Received: 11 May 2020
Accepted: 17 August 2020
First Online: 8 October 2020
Ethics approval and consent to participate
: The IMAP study was approved by a regional ethics committee (Comité de Protection des Personnes Nord-Ouest III) and registered at ExternalRef removed (no. ExternalRef removed). All participants gave their written informed consent to the study prior to enrollment.
: Not applicable
: Antoine Garnier-Crussard reports no competing interests.Salma Bougacha reports no competing interests.Miranka Wirth reports no competing interests.Claire André reports no competing interests.Marion Delarue reports no competing interests.Brigitte Landeau reports no competing interests.Florence Mézenge reports no competing interests.Elizabeth Kuhn reports no competing interests.Julie Gonneaud reports no competing interests.Anne Chocat reports no competing interests.Anne Quillard reports no competing interests.Eglantine Ferrand Devouge reports no competing interests.Vincent de la Sayette reports no competing interests.Denis Vivien reports no competing interests.Pierre Krolak-Salmon reports no competing interests.Gaël Chételat reports no competing interests.
